You are using an older browser version. Please use a supported version for the best MSN experience.

US panel weighs whether to OK Merck COVID-19 pill

U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. The FDA asked its outside experts Tuesday whether the agency should authorize the pill. (Nov. 30)
image beaconimage beaconimage beacon